Cellectar Biosciences, Inc. Increase (Decrease) in Deferred Liabilities
Cellectar Biosciences, Inc. (CLRB) reported Increase (Decrease) in Deferred Liabilities of -$7.64 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2018-03-21
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for the quarter ending 2014-03-31 was $1.38K, a 37.13% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for the quarter ending 2013-12-31 was $1.38K, a 37.13% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for the quarter ending 2013-09-30 was $2.06K, a 27.86% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for the quarter ending 2013-06-30 was $2.20K, a 26.48% decline year-over-year.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2017 was -$7.64K.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2016 was -$2.34K, a 303.57% decline from fiscal 2015.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2015 was $1.15K, a 74.67% decline from fiscal 2014.
- Cellectar Biosciences, Inc. increase (decrease) in deferred liabilities for fiscal 2014 was $4.54K, a 42.02% decline from fiscal 2013.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month | Increase (Decrease) in Deferred Liabilities 104 month | Increase (Decrease) in Deferred Liabilities 107 month | Increase (Decrease) in Deferred Liabilities 110 month | Increase (Decrease) in Deferred Liabilities 113 month | Increase (Decrease) in Deferred Liabilities 116 month | Increase (Decrease) in Deferred Liabilities 119 month | Increase (Decrease) in Deferred Liabilities 122 month | Increase (Decrease) in Deferred Liabilities 125 month | Increase (Decrease) in Deferred Liabilities 128 month | Increase (Decrease) in Deferred Liabilities 131 month | Increase (Decrease) in Deferred Liabilities 134 month | Increase (Decrease) in Deferred Liabilities 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | -$7.64K 10-K · filed 2018-03-21 | |||||||||||||||
| 2016-12-31 | -$2.34K 10-K · filed 2018-03-21 | |||||||||||||||
| 2015-12-31 | $1.15K 10-K · filed 2017-03-15 | |||||||||||||||
| 2014-12-31 | $4.54K 10-K/A · filed 2016-10-20 | |||||||||||||||
| 2014-03-31 | $1.38K 10-Q · filed 2014-05-14 | $2.76K derived: sum of 2 quarters · filed 2015-05-20 | $4.82K derived: sum of 3 quarters · filed 2015-05-20 | $7.01K derived: sum of 4 quarters · filed 2015-05-20 | $144.61K 10-Q · filed 2014-05-14 | |||||||||||
| 2013-12-31 | $1.38K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $3.44K derived: sum of 2 quarters · filed 2015-05-20 | $5.63K derived: sum of 3 quarters · filed 2015-05-20 | $7.83K 10-K · filed 2015-05-20 | $143.23K 10-K · filed 2014-03-19 | |||||||||||
| 2013-09-30 | $2.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $4.25K derived: sum of 2 quarters · filed 2013-11-13 | $6.45K 10-Q · filed 2013-11-13 | $8.64K derived: sum of 4 quarters · filed 2014-05-14 | $141.85K 10-Q · filed 2013-11-13 | |||||||||||
| 2013-06-30 | $2.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $4.39K 10-Q · filed 2013-08-12 | $6.59K derived: sum of 3 quarters · filed 2014-05-14 | $9.44K derived: sum of 4 quarters · filed 2014-05-14 | $139.79K 10-Q · filed 2013-08-12 | |||||||||||
| 2013-03-31 | $2.19K 10-Q · filed 2014-05-14 | $4.39K derived: sum of 2 quarters · filed 2014-05-14 | $7.24K derived: sum of 3 quarters · filed 2014-05-14 | $10.23K derived: sum of 4 quarters · filed 2014-05-14 | $137.60K 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | $2.19K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $5.05K derived: sum of 2 quarters · filed 2014-03-19 | $8.04K derived: sum of 3 quarters · filed 2014-03-19 | $11.02K 10-K · filed 2014-03-19 | $135.40K 10-K · filed 2013-03-28 | |||||||||||
| 2012-09-30 | $2.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $5.84K derived: sum of 2 quarters · filed 2013-11-13 | $8.83K 10-Q · filed 2013-11-13 | $11.81K derived: sum of 4 quarters · filed 2013-11-13 | $133.21K 10-Q · filed 2012-11-06 | |||||||||||
| 2012-06-30 | $2.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $5.97K 10-Q · filed 2013-08-12 | $8.96K derived: sum of 3 quarters · filed 2013-08-12 | $11.91K derived: sum of 4 quarters · filed 2013-08-12 | $130.35K 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $2.99K 10-Q · filed 2013-05-15 | $5.97K derived: sum of 2 quarters · filed 2013-05-15 | $8.93K derived: sum of 3 quarters · filed 2013-05-15 | $7.73K derived: sum of 4 quarters · filed 2013-05-15 | $127.37K 10-Q · filed 2012-05-04 | |||||||||||
| 2011-12-31 | $2.99K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $5.94K derived: sum of 2 quarters · filed 2013-03-28 | $4.75K derived: sum of 3 quarters · filed 2013-03-28 | $9.07K 10-K · filed 2013-03-28 | $124.38K 10-K · filed 2012-03-09 | |||||||||||
| 2011-09-30 | $2.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.76K derived: sum of 2 quarters · filed 2012-11-06 | $6.08K 10-Q · filed 2012-11-06 | $11.29K derived: sum of 4 quarters · filed 2012-11-06 | $121.39K 10-Q · filed 2011-11-07 | |||||||||||
| 2011-06-30 | -$1.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $3.13K 10-Q · filed 2012-08-09 | $8.34K derived: sum of 3 quarters · filed 2012-08-09 | $12.82K derived: sum of 4 quarters · filed 2012-08-09 | $118.44K 10-Q · filed 2011-08-12 | |||||||||||
| 2011-03-31 | $4.32K 10-Q · filed 2012-05-04 | $9.53K derived: sum of 2 quarters · filed 2012-05-04 | $14.01K derived: sum of 3 quarters · filed 2012-05-04 | |||||||||||||
| 2010-12-31 | $5.21K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-09 | $9.68K derived: sum of 2 quarters · filed 2012-03-09 | $9.97K 10-K · filed 2012-03-09 | |||||||||||||
| 2010-09-30 | $4.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $4.76K 10-Q · filed 2011-11-07 | ||||||||||||||
| 2010-06-30 | $289.00 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |